Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation

Anesthesiology

Volumn 103, Issue 3, 2005, Pages 576-584

  Keel, Marius ^a   Mica, Ladislav ^a   Stover, John ^a   Stocker, Reto ^a   Trentz, Otmar ^a   Härter, Luc ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; FAS ANTIBODY; FAS ANTIGEN; FLUORESCENT DYE; GLIOTOXIN; I KAPPA B; PROPIDIUM IODIDE; RHODAMINE 123; THIOPENTAL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTOPENIA; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 24144442149     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200509000-00021     Document Type: Article

References (47)

1. Sosin DM, Sacks JJ, Smith SM: Head injury-associated deaths in the United-States from 1979-1986. JAMA 1989; 262:2251-5
2. Gennarelli TA, Champion HR, Copes WS, Sacco WJ: Comparison of mortality, morbidity, and severity of 59713 head injured patients with 114447 patients with extracranial injuries. J Trauma 1994; 37:962-8
3. Saul TG, Ducker TB: Effect of intracranial pressure monitoring and aggressive treatment on mortality in severe head injury. J Neurosurg 1982; 56:498-503
4. Miller JD, Stanek A, Langfit TW: Concepts of cerebral perfusion pressure and vascular compression during intracranial hypertension. Brain Res 1971; 34:411-32
5. Ertel W, Keel M, Stocker R, Imhof HG, Leist M, Steckholzer U, Tanaka M, Trentz O, Nagata S: Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury. J Neuroimmunol 1997; 80:93-6
6. Härter L, Keel M, Hentze H, Leist M, Ertel W: Caspase-3 activity is present in cerebrospinal fluid from patients with traumatic brain injury. J Neuroimmunol 2001; 121:76-8
7. Tokutomi T, Morimoto K, Miyagi T, Yamaguchi S, Ishikawa K, Shigemori M: Optimal temperature for the management of severe traumatic brain injury: Effect of hypothermia on intracranial pressure, systemic and intracranial hemodynamics, and metabolism. Neurosurgery 2003; 52:102-12
8. Michenfelder JD: The interdependency of cerebral functional and metabolic effects following massive doses of thiopental in the dog. ANESTHESIOLOGY 1974; 41:231-6
9. Donegan JH, Traystman FJ, Koehler RC, Jones Jr, MD Rogers MC: Cerebrovascular hypoxic and autoregulatory responses during reduced brain metabolism. Am J Physiol 1985; 249:H421-9
10. Sato M, Tanaka S, Suzuki K, Kohama A, Fujii C: Complications associated with barbiturate therapy. Resuscitation 1989; 17:233-41
11. Schalen W, Messeter K, Nordström CH: Complications and side effects during thiopentone therapy in patients with severe head injuries. Acta Anaesthesiol Scand 1992; 36:369-77
12. Stover JF, Stocker R: Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury. Eur J Clin Pharmacol 1998; 54:529-43
13. Cohen JJ: Apoptosis: Mechanisms of life and death in the immune system. Allergy Clin Immunol 1999; 103:548-54
14. Neuwelt EA, Kikuchi K, Hill SA, Lipsky P, Frenkel E: Barbiturate inhibition of lymphocyte function: Differing effects of various barbiturates used to induce coma. J Neurosurg 1982; 56:254-9
15. Green D, Kroemer G: The central executioners of apoptosis: Caspases or mitochondria? Cell Biol 1998; 8:267-71
16. Rathmell JC, Thompson CB: The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17:781-828
17. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999; 17:331-67
18. Nagata S, Golstein P: The Fas death factor. Science 1995; 267:1449-56
19. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1(Fas/CD95). Nature 1995; 373:438-41
20. Smets LA: Programmed cell death (apoptosis) and response to anticancer drugs. Anticancer Drugs 1994; 5:3-9
21. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R: Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res 1997; 57:3331-4
22. Xie H, Seward RJ, Huber BT: Cytokine rescue from glucocorticoid induced apoptosis in T cells is mediated through inhibition of IkappaBalpha. Mol Immunol 1997; 34:987-94
23. Thornberry NA: Caspases: Key mediators of apoptosis. Chem Biol 1998; 5:R97-103
24. Jäättelä M, Tschopp J: Caspase-independent cell death in T lymphocytes. Nat Immunol 2003; 4:416-23
25. Stover JF, Lenzlinger PM, Stocker R, Morganti-Kossmann MC, Imhof HG, Trentz O, Kossmann T: Thiopental in CSF and Serum correlates with prolonged loss of cortical activity Eur. Neurol 1998; 39:223-8
26. Loop T, Humar M, Pischke S, Hoetzel A, Schmidt R, Fahl HL, Geiger KK, Pannen BH: Thiopental inhibits tumor necrosis factor α-induced activation of nuclear factor κB through suppression of κB kinase activity. ANESTHESIOLOGY 2003; 99:360-7
27. Pahl HL: Activators and target genes of rel/NF-kappaB transcription factors. Oncogene 1999; 189:321-5
28. Vermes I, Haanen C, Richel DJ, Schaafsma MR, Kalsbeek-Batenburg E, Reutelingsperger CPM: Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol 1997; 98:8-13
29. Keel M, Ungethüm U, Steckholzer U, Niederer E, Hartung T, Trentz O, Ertel W: Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997; 90:3356-63
30. Härter L, Keel M, Hentze H, Steckholzer U, Ungethüm U, Trentz O, Ertel W: Spontaneous in contrast to CD95-induced neutrophil apoptosis is independent of caspase activity. J Trauma 2001; 50:982-8
31. Delogu G, Antonucci A, Moretti S, Marandola M, Tellan G, Signore M, Famularo G: Oxidative stress and mitochondrial glutathione in human lymphocytes exposed to clinically relevant anesthetic drug concentrations. J Clin Anesth 2004; 16:189-94
32. Nestler EJ, Aghajaninan GK: Molecular and cellular basis of addiction. Science 1997; 278:58-63
33. Yin D, Tuthil D, Mufson RA, Shi Y: Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med 2000; 191: 1423-8
34. Friesen C, Herr I, Krammer HP, Debatin KM: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 1996; 2:574-7
35. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann W, Stremmel W, Krammer HP, Galle PR: Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997; 99:403-13
36. Nair MPN, Schwartz SA, Polasani R, Hou J, Sweet A, Chadha KC: Immunoregulatory effects of morphine on human lymphocytes. Clin Diagn Lab Immunol 1997; 4:127-32
37. Yin D, Mufson A, Wang R, Shi Y: Fas-mediated cell death promoted by opioids (letter). Nature 1999; 397:218
38. Oka M, Hirazawa K, Yamamoto K, Iizuka N, Hazama S, Suzuki T, Kobayashi N: Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg 1996; 223:434-40
39. Borner C, Monney L: Apoptosis without caspases: An inefficient molecular guillotine? Cell Death Differentiation 1999; 6:497-507
40. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J: Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 1:489-95
41. Wolf BB, Goldstein JC, Stennicke HR, Beere H, Amarante-Mendes GP, Salvesen GS, Green DR: Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999; 94:1683-92
42. Roberts LR, Adjei PN, Gores GJ: Cathepsins as effector proteases in hepatocyte apoptosis. Cell Biochem Biophys 1999; 30:71-88
43. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A: Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 1996; 15:3861-70
44. Grimm LM, Osborne BA: Apoptosis and the proteaseome. Results Probl Cell Differ 1999; 23:209-28
45. Humar M, Pischke SE, Loop T, Hoetzel A, Schmidt R, Klaas C, Pahl HL, Geiger KK, Pannen BH: Barbiturates directly inhibit the calmodulin/calcineurin complex: a novel mechanism of inhibition of nuclear factor of activated T cells. Mol Pharmacol 2004; 65:350-61
46. Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN, Haslett C, Rossi AG: NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 1999; 274:4309-18
47. Humar M, Andriopoulos N, Pischke SE, Loop T, Schmidt R, Hoetzel A, Roesslein M, Pahl HL, Geiger KK, Pannen BH: Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1. J Pharmacol Exp Ther 2004; 311:1232-40